The results of the meta-analysis did not show significant differences (p > 0.05) between low GI and higher GI diets with respect to adiponectin and C-reactive protein in patients with type 2 diabetes (Table 5). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.